Adjuvant Therapy for Melanoma: Past, Current, and Future Developments
This review describes the progress that the concept of adjuvant therapies has undergone in the last 50 years and focuses on the most recent development where an adjuvant approach has been scientifically evaluated in melanoma clinical trials. Over the past decade the development of immunotherapies an...
Main Authors: | Alessandro A. E. Testori, Silvia Chiellino, Alexander C.J. van Akkooi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/7/1994 |
Similar Items
-
The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022
by: Paolo A. Ascierto, et al.
Published: (2023-04-01) -
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
by: Paolo A. Ascierto, et al.
Published: (2019-05-01) -
Neo-Adjuvant Therapy for Metastatic Melanoma
by: Anke M. J. Kuijpers, et al.
Published: (2024-03-01) -
Adjuvant treatments in melanoma
by: Luka Simetić, et al.
Published: (2021-01-01) -
Novel Biomarkers and Therapeutic Targets for Melanoma
by: Noa Sabag, et al.
Published: (2022-10-01)